Genicular Artery Embolization
Patient selection and outcomes in knee osteoarthritis, with attention to imaging and molecular biomarkers.
A clinical research program centered on musculoskeletal embolization, quantitative angiographic imaging, MRI-guided therapy, and trial workflows that make patient selection more precise.
Patient selection and outcomes in knee osteoarthritis, with attention to imaging and molecular biomarkers.
Musculoskeletal embolization strategies for shoulder pathology and arterial anatomy mapping.
Perfusion analysis, angiographic blush assessment, and time-density curve interpretation.
Feasibility of MRI guidance as an alternative or complement to fluoroscopy and CT.
Outcomes research, longitudinal follow-up, and structured trial coordination.
Predictive modeling and decision support for selecting the right patient for the right intervention.
I am currently working as a Clinical Research Fellow in the Department of Interventional Radiology at Brigham and Women's Hospital / Harvard Medical School, where I am actively involved in clinical trials and translational research focused on embolization therapies.
My work includes serving as a co-investigator and research coordinator for ongoing trials. I am involved in patient screening, eligibility assessment, procedural planning, and angiographic interpretation, with a focus on evaluating embolization endpoints and treatment response.
I also perform quantitative imaging analysis using digital subtraction angiography, angiographic blush assessment, and time-density curve analysis. I use ImageJ/FIJI and 3D Slicer for image processing, segmentation, and perfusion analysis to better understand treatment efficacy and optimize patient selection.
My prior research experience includes work as a research assistant at LUMS, where I investigated immune dysfunction in type 2 diabetes and its role in increased susceptibility to infectious diseases. I also have laboratory experience in histopathology, tissue engineering, genetics, and molecular biology techniques including PCR, ELISA, and flow cytometry.
Embolization trial focused on musculoskeletal applications. Responsibilities include patient screening, angiographic analysis, and longitudinal outcomes tracking.
Coordinating procedural planning, patient eligibility assessment, and follow-up data collection across enrolled participants.